Pluri Inc. (PLUR) stock
PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$0.92−0.06 (-6.62%)
Close on Nov 18, 2026Market cap $11.30MP/E –Yield –
Pluri revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Pluri's revenue for the twelve months ending Jun 30, 2026 was $1.02M, down 24.0% year over year. For fiscal 2026 it was $1.02M, down 24.0% from the year before. Over ten years it grew 10.4% a year on average. The highest annual figure on record is $2.85M in fiscal 2016.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $1.02M | -24.0% |
| FY2025 | Jun 30, 2025 | $1.34M | +309.8% |
| FY2024 | Jun 30, 2024 | $326.00K | +13.6% |
| FY2023 | Jun 30, 2023 | $287.00K | +22.6% |
| FY2022 | Jun 30, 2022 | $234.00K | +917.4% |
| FY2020 | Jun 30, 2020 | $23.00K | -57.4% |
| FY2019 | Jun 30, 2019 | $54.00K | +8.0% |
| FY2018 | Jun 30, 2018 | $50.00K | -98.2% |
| FY2016 | Jun 30, 2016 | $2.85M | +651.2% |
| FY2015 | Jun 30, 2015 | $379.00K | 0.0% |
| FY2014 | Jun 30, 2014 | $379.00K | -44.2% |
| FY2013 | Jun 30, 2013 | $679.00K | -5.2% |
| FY2012 | Jun 30, 2012 | $716.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $335.00K | -15.8% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $167.00K | -60.9% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $198.00K | +7.0% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $316.00K | -3.1% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $398.00K | +314.6% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $427.00K | +501.4% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $185.00K | +76.2% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $326.00K | +503.7% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $96.00K | -13.5% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $71.00K | -18.4% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $105.00K | +5150.0% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $54.00K | -37.9% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $111.00K | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $87.00K | -62.8% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $2.00K | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $87.00K | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $0 | -100.0% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $234.00K | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $0 | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $0 | -100.0% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $23.00K | +475.0% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $0 | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $0 | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $50.00K | 0.0% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $4.00K | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $0 | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $0 | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $50.00K | – |
See a number that looks wrong?